Manulife Financial
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +11.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 0.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 14:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 16.8x | Better than 52% |
| Forward P/E | 14.2x | Better than 59% |
| Price / Sales | 2.0x | Better than 57% |
| P/E vs own 5-yr range | 100th pctl | Better than 2% |
Growth B+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 29.9% | Better than 90% |
| Net income CAGR (3Y) | -5.4% | Better than 33% |
| Free cash flow CAGR (3Y) | 24.5% | Better than 69% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Net margin | 9.9% | Better than 59% |
| Return on equity | 11.8% | Better than 58% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -3.8% | Better than 65% |
| 6-month return | 8.0% | Better than 69% |
| 12-month return (ex latest month) | 32.9% | Better than 72% |
| Distance below 52-week high | 10.8% | Better than 81% |
Financial Health A+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Debt to assets | 1.4% | Better than 90% |
| Interest coverage | 5.6x | Better than 59% |
| Free cash flow / net income | 555.3% | Better than 93% |
Analyst View C-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 60.0% | Better than 36% |
| Upside to average target | 14.7% | Better than 22% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 41.87
- Open
- 41.69
- Day range
- 40.85 - 41.97
- Avg price
- 41.26
- Volume
- 2.51M
- Turnover
- 103.57M
- Turnover ratei
- 0.15%
- Volume ratioi
- 0.48
- Amplitudei
- 2.69%
- 52-week rangei
- 31.75 - 45.82
Valuation
- P/Ei
- 19.10
- P/E (TTM)i
- 16.80
- P/Bi
- 2.04
- EPSi
- 2.14
- Book value / shi
- 20.06
- Net profit
- 3.54B
- Net assets
- 33.13B
Share structure
- Market cap
- 67.55B
- Float capi
- 67.43B
- Shares out
- 1.65B
- Float sharesi
- 1.65B
Dividend & listing
- Div yield (TTM)i
- 3.26%
- Dividend (TTM)
- 1.33
- Listing date
- 1970-01-01
10.8% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-14.63M net over the window
Short interest
- Shares short
- 12.77M
- % of floati
- 0.77%
- Days to coveri
- 9.26
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Manulife Financial (MFC)?
Manulife Financial last traded at 40.89. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Manulife Financial's market cap?
About 67.55B.
What is the P/E ratio of Manulife Financial?
The trailing twelve-month P/E is 16.80, above its own 5-year average of 11.06 — toward the top of its historical range (99.60% percentile). See the Valuation tab for the full history.
Does Manulife Financial pay a dividend?
Yes. The trailing dividend yield is 3.26%. The 2025 payout was up 6.9% from 2024. See the Dividends tab for the full payment history.
Is Manulife Financial a buy according to analysts?
The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 46.92, which implies 14.7% upside from the current price. This is not investment advice.
What is Manulife Financial's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Manulife Financial a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:28 · For reference only, not investment advice and not tailored to your situation.
Manulife Financial discussion 0 comments